Clinical Trials Directory

Trials / Completed

CompletedNCT03790280

High Frequency Oscillation in Pediatric Epilepsy Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
University of California, Los Angeles · Academic / Other
Sex
All
Age
0 Years – 21 Years
Healthy volunteers
Not accepted

Summary

High Frequency Oscillation (HFO) on ElectroCorticoGraphy (ECoG) has been identified as a new biomarker for epileptogenic tissue. The purpose of this study is to see if epilepsy surgery guided by the combination of HFO on ECoG and standard clinical practice can result in a greater likelihood of seizure freedom, versus standard clinical practice alone, without HFOs.

Detailed description

Intra-operative electrocorticography (ECoG), based on interictal spike and spike patterns, is performed to optimize delineation of the epileptogenic tissue in the operating room during epilepsy surgery. Similarly, extra-operative electrocorticography is often recorded over days to weeks with intracranial grids and depth electrodes, when the epileptogenic zone is not clearly localized with non-invasive studies and/or with intra-operative ECoG. Surgical resection following extra-operative ECoG is then "tailored' by the seizure onset zone as the gold standard. High frequency oscillations have been identified as a more precise biomarker for epileptogenic tissue. The aim of this double-blind randomized surgical trial is to determine if HFO- tailored surgery combining HFOs and current standard of care, compared to current standard of care alone, will lead to a better seizure outcome.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHFO analysisWe hypothesize that the strategy of incorporating HFO data to a standard ECoG-guided resection in pediatric epilepsy surgery will result in improved postoperative seizure outcome than the traditional approach.

Timeline

Start date
2018-11-29
Primary completion
2021-07-01
Completion
2021-07-01
First posted
2018-12-31
Last updated
2023-09-01
Results posted
2023-09-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03790280. Inclusion in this directory is not an endorsement.